Upload
Featured Recent Articles Topics Login Upload

Search Results for 'Cangrelor-Prasugrel'

Cangrelor-Prasugrel published presentations and documents on DocSlides.

Pharmacodynamic Effects of
Pharmacodynamic Effects of
by luanne-stotts
Cangrelor. . on . Platelet P2Y. 12. Receptor . ...
Cangrelor in Patients with Coronary Artery Disease Pre-treated with Ticagrelor: The Switching Antip
Cangrelor in Patients with Coronary Artery Disease Pre-treated with Ticagrelor: The Switching Antip
by beatrice
Luis Ortega-Paz, MD, PhD. 1. ; Francesco Franchi, ...
Cangrelor : Friend or Foe? -
Cangrelor : Friend or Foe? -
by ariel
Cangrelor. : Not the CHAMPION We Hoped For. James ...
Antiplatelet Agents Mohammad Sistanizad
Antiplatelet Agents Mohammad Sistanizad
by blindnessinfluenced
Associate Professor of Clinical Pharmacy,. SBMU. C...
Prasugrel vs ticagrelor in acute coronary syndromes
Prasugrel vs ticagrelor in acute coronary syndromes
by tawny-fly
Giuseppe . Biondi-Zoccai. , MD. Sapienza Universi...
ACCOAST: no difference
ACCOAST: no difference
by debby-jeon
ACCOAST: no difference in efficacy endpoin...
Switching from dual antiplatelet therapy with aspirin plus a P2Y
Switching from dual antiplatelet therapy with aspirin plus a P2Y
by brown
12. inhibitor to dual pathway inhibition with asp...
Sumith Aleti , MD, MPH, FACC
Sumith Aleti , MD, MPH, FACC
by dorothy
OHHI Cardiology Group. Antiplatelet and Anticoagul...
On behalf of the TRILOGY ACS Investigators
On behalf of the TRILOGY ACS Investigators
by lam
Prasugrel versus clopidogrel for patients with . U...
ACCP Cardiology PRN Journal Club
ACCP Cardiology PRN Journal Club
by marina-yarberry
ACCP Cardiology PRN Journal Club 27 September 20...
De-escalation versus escalation of antiplatelet therapy in elderly ACS patients: insight from the ANTARCTIC trial.
De-escalation versus escalation of antiplatelet therapy in elderly ACS patients: insight from the ANTARCTIC trial.
by debby-jeon
De-escalation versus escalation of antiplatelet t...
ISAR-REACT 5, comment
ISAR-REACT 5, comment
by trish-goza
ISAR-REACT 5, comment G. Montalescot Institute o...
When should we start a
When should we start a
by myesha-ticknor
P2Y. 12. inhibitor . in patients with an acute c...
Application
Application
by natalia-silvester
0 Phase 1 Phase 2 Phase 3 Therapeutic area Cardiov...
Canadian Diabetes Association Clinical Practice Guidelines
Canadian Diabetes Association Clinical Practice Guidelines
by test
Acute Coronary Syndromes and Diabetes. Chapter 26...